CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Richter Gedeon Vegyeszeti Gyar Nyrt is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Richter Gedeon Vegyeszeti Gyar Nyrt
Gyomroi ut 19-21.
Phone: +36 14314000p:+36 14314000 BUDAPEST, 1103  Hungary Ticker: RICHTERRICHTER

Business Summary
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
(Source: F-4)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Supervisory Board Attila L.Chikan 79 1/1/2000 1/1/2000
Non-Executive Independent Chairman of the Board Szilveszter E.Vizi 87 3/1/2024
Lifetime Honorary Chairman ErikBogsch 74 3/1/2024 1/1/2017
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
BCI Pharma SA av. de lhopital, 11 Liege Belgium

Business Names
Business Name
BCI Pharma SA
Farnham Laboratories Ltd.
Gedeon Richter Ltd.
12 additional Business Names available in full report.

General Information
Number of Employees: 11,603 (As of 12/31/2023)
Outstanding Shares: 182,493,897 (As of 3/31/2024)
Shareholders: 210
Stock Exchange: BDP
Fax Number: +36 12606650


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, July 14, 2024